The association between cardiovascular risk and cardiovascular magnetic resonance measures of fibrosis: the Multi-Ethnic Study of Atherosclerosis (MESA)

Table 1 Endpoint prediction for each of 14 risk scores

Risk scores*	Endpoint prediction	Risk factors included in model ^‡
Edinburgh (CHD)¹	10 year CHD	Age, Gender, Smoker, Diabetes, LVH, SBP, Chol, HDL
Edinburgh (CVD)¹	10 year CVD	Age, Gender, Smoker, Diabetes, LVH, SBP, Chol, HDL
Death (CHD)¹	10 year death from CHD	Age, Gender, Smoker, Diabetes, LVH, SBP, Chol, HDL
Death (CVD)¹	10 year death from CVD	Age, Gender, Smoker, Diabetes, LVH, SBP, Chol, HDL
Myocardial Infarction (MI)¹	10 year MI	Age, Gender, Smoker, Diabetes, LVH, SBP, Chol, HDL
Stroke¹	10 year stroke	Age, Gender, Smoker, Diabetes, LVH, SBP, Chol, HDL
Framingham (CVD)³	10 year CVD	Age, Gender, Smoker, SBP, Chol, HDL, HTN Med
National Cholesterol Education Program (NCEP)⁴	10 year CHD	Age, Smoker, Diabetes, SBP, HDL, LDL
British National Formulary (BNF)¹	10 year CVD	Age, Gender, Smoker, Diabetes, LVH, SBP, Chol, HDL
ASSIGN¹	10 year CVD	Age, Gender, Smoker, Diabetes, SBP, Chol, HDL, Cigarettes, MI Fam
PROCAM²	10 year CHD	Diabetes, SBP, HDL, LDL, Trig, Glucose, HTN Med
Reynolds⁵	10 year CHD	Age, Gender, Smoker, Diabetes, SBP, Chol, HDL, CRP, Hemoglobin, MI Fam
MESA⁶	5 year HF	Age, Gender, Smoker, BMI Grade, SBP, Heart Rate, Diabetic Status, BNP, LV Mass
Atherosclerotic Cardiovascular Disease (ASCVD)⁷	10 year CVD	Age, Gender, Smoker, Diabetes, SBP, Chol, HDL

*References indicated below.
CVD – Cardiovascular Disease; CHD – Coronary Heart Disease; HF – Heart Failure; Chol – Total Cholesterol; LVH – Left Ventricular Hypertrophy; SBP – Systolic Blood Pressure; HTN Med – Hypertension Medication; MI Fam – Family History of Myocardial Infarction; BNP – proBNP levels; LV Mass – Left Ventricular Mass; Trig – triglycerides; BMI – body mass index; CRP – c reactive protein.
^‡Risk Scores were calculated as in [25].
^1-7See Appendix for Risk score references.

ISSN: 1532-429X